Oncogene news from around the world
Published in Nature Medicine, results of WINTHER trial has shown that RNA profiling together with DNA testing,…
In recent years, it’s become clear that RNA-binding proteins play a major role in cancer…
Only about one in four people diagnosed with acute myelogenous leukaemia (AML) survive five years…
Scientists in Cambridge and London have developed a catalogue of DNA mutation ‘fingerprints’ that could…
Researchers from the Experimental Oncology Group, led by Mariano Barbacid at the Spanish National Cancer…
Melanoma is one of the most aggressive types of skin cancer, but recent advances in…
11,000 people are predicted to die from acute myeloid leukemia (AML) in 2019, according to…
A consortium of researchers led by Georgetown Lombardi Comprehensive Cancer Center investigators have completed the…
Medications known as PARP inhibitors have emerged as a promising therapy for several forms of…
Fewer than a quarter of breast cancer patients and a third of ovarian cancer patients…